Y-mAbs Therapeutics, Inc. today announced that it will report its financial results for the third quarter ended September 30, 2020 on Thursday, November 5, 2020, after the close of the U.S. financial markets. The announcement will be followed by a conference call and webcast with the investment community on Friday, November 6, 2020, at 9 a.m. ET. Participating on the call from Y-mAbs will be Thomas Gad, founder, Chairman and President; Dr. Claus Moller, Chief Executive Officer; and Bo Kruse, Chief Financial Officer.
Read the full press release here